Novel pharmacologic therapies for cystic fibrosis.
P. Zeitlin
semanticscholar +1 more source
Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1β, and nuclear factor κB in trinitrobenzene sulphonic acid induced colitis in rats [PDF]
Mi-Hwa Song, Bing Xia, Jing Li
openalex +1 more source
Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease. [PDF]
Diamantidis MD +5 more
europepmc +1 more source
Maternal sodium butyrate supplement elevates the lipolysis in adipose tissue and leads to lipid accumulation in offspring liver of weaning-age rats [PDF]
Jiabin Zhou +4 more
openalex +1 more source
Elafibranor, a dual PPARα and PPARδ agonist, reduces alcohol-associated liver disease: Lessons from a mouse model. [PDF]
Pirola L.
europepmc +1 more source
Butyrate ameliorates DSS-induced ulcerative colitis in mice by facilitating autophagy in intestinal epithelial cells and modulating the gut microbiota through blocking the PI3K-AKT-mTOR pathway. [PDF]
Li R +5 more
europepmc +1 more source
Crystal structure of the antibiotic SY-1 (20-deoxy-salinomycin): sodium 2-(6-[2-(5-ethyl-5-hydroxy-6-methyl-tetrahydro-pyran-2-yl)-2,10,12-trimethyll, 6,8-trioxa-dispiro[4.1.5.3]pentadec-13-en-9-yl]-2-hydroxy-l,3-dimethyl- 4-oxo-heptyl-5-methyl-tetrahydro-pyran-2-yl)-butyrate–methanol solvate (1:0.69), C42H69NaO10 · 0.69CH3OH [PDF]
E. F. Paulus, László Vértesy
openalex +1 more source
Butyric acid and prospects for creation of new medicines based on its derivatives: a literature review. [PDF]
Gerunova LK +9 more
europepmc +1 more source

